Internet of Things Inc Sees Surge In Demand For ThermalPass

Internet of Things Inc (TSXV: ITT) (OTC: INOTF) reported this morning that it is experiencing a surge in demand for its fever detection system known as ThermalPass, due in part to the ongoing coronavirus pandemic while businesses attempt to restart operations.

The company announced this morning that it is currently continuing discussions with a range of potential clients, which includes large property management companies, nationwide retail chains, as well as various levels of governments whom are wanting to utilize ThermalPass so they can open their facilities safely.

The ThermalPass system is superior to similar product offerings currently available on the market in that it uses medical grade sensors versus that of cameras. Infrared cameras tend to be less accurate, while being more costly and invade on privacy – something which privacy watchdogs have been clamoring over as of late.

ThermalPass’ AI-powered tech enables for fast, touch-free scanning on individuals as they walk through the device, measuring temperatures from a distance by detecting a persons infrared energy. Should an abnormality in temperature be detected, the system instant and quietly alerts security personnel, enabling a secondary check to occur while maintaining traffic flow. ThermalPass is intended to be placed at points of access for public spaces such as office buildings, stadiums, airports, and schools. The tech itself was developed by AI Labs, ITT’s subsidiary, in conjunction with Commersive Solutions, a developer of point-of-sale tech that creates unique retail experiences.

“As the spread of contagions is a major concern, governments and businesses must implement solutions to put minds at ease as people get back to work. While we are not happy to see this pandemic prolonged, we are proud to have created a mitigating solution that is being met with such fervent commercial interest. ThermalPass is positioned to help all types of corporations and institutions rebuild confidence as the world recovers from this unprecedented economic and health crisis.”
Michael Lende, CEO & President ITT

Furthermore, the company is has applied to Health Canada for its Medical Device Establishment License under the streamlined interim order process.

Internet of Things Inc last traded at $0.045 on the TSX Venture.


FULL DISCLOSURE: Internet of Things Inc is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Internet of Things Inc on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Agnico Q1 Earnings Results Overshadowed By A Sinking Gold Price

Why More People Are Starting to Feel Broke | Darrell Thomas – VRIC Media

Newmont Q1 Earnings: A Billion In Free Cash Flow… A Month!

Recommended

Altamira Gold Extends Maria Bonita Porphyry System Westward With 70.6 Metres At 0.51 g/t Hit

Antimony Resources Reports 13.9% Antimony in Latest Drill Core at Bald Hill

Related News

Coronavirus Pandemic Could Wipe Out Up To $30 Trillion from the Global Economy: McKinsey Global Institute

If production disruptions last for a span of at least 100 days amid the coronavirus...

Saturday, August 15, 2020, 11:16:00 AM

Lyft Lays Off Employees, Reduces Salaries Amid Decreased Demand for Ride-sharing Services

Lyft Inc (NASDAQ: LYFT) has not been faring too well through the coronavirus pandemic. The...

Friday, May 1, 2020, 08:24:26 AM

Revive Therapeutics Signs MOU With Attwill Medical, Manufacturer For Vaxart, For Phase 3 Clinical Trials

Revive Therapeutics (CSE: RVV) (OTC: RVVTF) is one step closer to conducting its phase 3...

Friday, August 14, 2020, 08:50:35 AM

Indebted Airbnb Superhosts Faced With Financial Difficulties Amid Pandemic

Nationwide lockdowns have ravaged the US economy, significantly reducing a multitude of industries to bare...

Thursday, April 30, 2020, 05:02:00 PM

Revive Therapeutics Sees FDA Recommend Phase 3 For COVID-19 Related Study Of Bucillamine

Revive Therapeutics (CSE: RVV) announced major news this morning related to its ongoing study of...

Thursday, April 23, 2020, 09:06:28 AM